رجوع
نطاق اليوم
KWD 6.63
KWD 7.07
نطاق 52 أسبوعًا
KWD 2.41
KWD 8.72
حجم التداول
760,162
متوسط 50 يوم / 200 يوم
KWD 6.41
/
KWD 5.73
الإغلاق السابق
KWD 7.14
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.0 | 0.4 |
| P/B | 2.9 | 2.9 |
| ROE % | -109.9 | 3.9 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 12.50
+87.1%
Low: KWD 9.00
High: KWD 16.00
ربحية السهم المستقبلية
-KWD 1.73
الإيرادات المقدّرة
3.68M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.17
KWD 1.17 – KWD 1.17
|
456.29M | 2 |
| FY2029 |
KWD 0.15
KWD 0.15 – KWD 0.15
|
279.56M | 4 |
| FY2028 |
-KWD 0.96
-KWD 1.48 – -KWD 0.39
|
107.00M | 6 |
No quarterly estimates available
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Debt/Equity of 0.12 — conservative balance sheet
Negative free cash flow of -157.44M
PEG of 0.08 suggests growth is underpriced
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-109.90%
ROIC-66.81%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.12
Current Ratio6.14
Interest Coverage0.00
التقييم
P/E Ratio
-2.99
Forward P/EN/A
P/B Ratio2.89
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -174.33M |
| ROE | -109.90% | ROA | -74.97% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -157.44M |
| ROIC | -66.81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 6.14 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.99 | Forward P/E | N/A |
| P/B Ratio | 2.89 | P/S Ratio | N/A |
| PEG Ratio | 0.08 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -30.25% | ||
| Market Cap | 520.44M | Enterprise Value | 481.70M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 8.09M | 13.62M |
| Net Income | -174.33M | -124.70M | -96.02M | -85.98M | -72.19M |
| EPS (Diluted) | -1.99 | -3.06 | -4.83 | -10.10 | -10.14 |
| Gross Profit | -1.64M | -2.46M | -2.58M | 8.09M | 13.62M |
| Operating Income | -179.21M | -129.73M | -104.32M | -106.45M | -72.25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 232.54M | 188.66M | 164.94M | 260.25M | 232.38M |
| Total Liabilities | 52.53M | 51.42M | 38.46M | 48.59M | 24.17M |
| Shareholders' Equity | 180.01M | 137.25M | 126.48M | 211.67M | 208.21M |
| Total Debt | 21.16M | 24.18M | 26.27M | 28.55M | 2.06M |
| Cash & Equivalents | 59.90M | 80.24M | 74.02M | 155.38M | 119.14M |
| Current Assets | 205.46M | 157.30M | 129.73M | 219.64M | 222.61M |
| Current Liabilities | 33.47M | 30.26M | 14.52M | 22.51M | 23.60M |